Expert Urologist Dr. David Samadi Educates on Prostate Cancer

Mitt Romney recently announced that last summer he underwent surgery to treat a slow-growing tumor found in his prostate. Dr. David Samadi, Chairman of Urology at Lenox Hill Hospital published an article to clarify for readers the implications of getting diagnosed with prostate cancer. According to Dr. David Samadi, when the cancer is still localized within the prostate, so it hasn’t metastasized and spread to other parts of the body, the prognosis for the patient is excellent, depending on the treatment option they choose.

Men with localized prostate cancer can have their prostates removed by surgery or they can undergo radiation treatment. They must choose. Radiation therapy uses targeted radiation to attempt to kill all the cancer cells. Dr. David Samadi always advises these patients to remove their prostate. Because all the cancer cells are in the prostate, they are entirely removed along with the prostate. The success rate for the patients who have their prostates removed by surgery is close to 100%. According to studies, men who receive the radiation therapy have twice the death rate. And, according to the studies, they are one-and-a-half times more likely sooner than the men who choose the surgery.

Dr. David Samadi mentions another possible consequence of receiving radiation therapy that is not known by many people. Radiation is a known carcinogen. That is, radiation causes cancer. And this is just as true of the radiation therapy used to treat cancer. Every exposure to radiation raises the patient’s risk of developing other tumors. Men receiving radiation therapy for prostate cancer have an increased risk of cancers of the bladder and rectum, and even of developing more prostate cancer in the future. Also, it’s difficult to perform prostate surgery after radiation therapy. If the man receives radiation instead of surgery and later discovers the cancer has spread to other parts of the body, the chance of surviving for five or more years drops to 30%.

In 2007, Dr. David Samadi went to work at Mt Sinai School of Medicine. He became their Chief of Robotics and Minimally Invasive Surgery. by 2012 he earned $6.7 million, the highest-paid doctor in New York City. A year later, he moved to Lenox Hill Hospital where he is also the Chief of Robotic Surgery. He belongs to the American Medical Association and the American Urological Association. He attracts attention to his practice by appearing in the media more than most doctors.


Oncotarget: Publishing New Cancer Treatment Methods

Two brilliant oncologists from the Roswell Park Cancer Insitute managed to develop an online medical journal that can be reviewed by the members of the scientific community. Dr. Mikhail Blagosklonny and Andrei V. Gudkov are the proponents of the online medical journal entitled Oncotarget, and they are currently serving as the website’s editors in chief. Their extensive knowledge about cancer has given them the idea to create an online medical journal, and they wanted to post all information that they know online so that other scientists can see it as well. They are also encouraging other oncologists worldwide to submit their discoveries about cancer to broaden the knowledge of the scientific community about the disease. Established in 2010, Oncotarget managed to reach millions of people around the world, and the online medical journal is now releasing articles twice a week. Aside from cancer, the online medical journal is also incorporating articles that tackle about fatal and incurable diseases, to help scientists discover a possible treatment or cure in the future. Check the journal at SCImago Journal & Country Rank.

Despite the advancement of technology and medicine, cancer remains an incurable disease. However, oncologists are still optimistic that the cure for the disease can be discovered one day, especially now that an online medical journal like Oncotarget exists. Today, people are trying to cope with treatment that has adverse side effects like chemotherapy, but in the future, the cure for cancer can be introduced in the form of a pill, and it can be dispatched all throughout the globe for hospitals to use. Scientists are sharing this information through Oncotarget, and it has been a habit for them to speculate and share their insights as to how cancer can be eradicated using the present technology that we have.

Learn more:


Oncotarget continues to become the leading resource for scientists around the world who are trying to look for scholarly articles when dealing with cancer and other fatal diseases. Dr. Mikhail Blagosklonny and Andrei V. Gudkov are also encouraging other oncologists around the world to contribute some knowledge that will help other oncologists on the other side of the planet deal with cancer. Download output styles at